Phantom Neuro has raised $19 million to develop its innovative wristband-like device designed to help amputees control their prosthetic limbs. The startup has received FDA designations as a Breakthrough Device and for its TAP program, facilitating its commercialization. Their technology, leveraging the concept of phantom limbs, boasts a 94% accuracy rate in non-invasive tests. With strategic backing from Ottobock and other investors, Phantom aims to expand applications beyond prosthetics. The company has now raised a total of $28 million and plans to enhance its neural interface technology.